Transplantation Therapy
Imunother Limited Company holds intellectual property and preclinical data for an entirely novel therapeutic for the facilitation of organ transplantation.
Please contact Dr. Marcel Priest, CEO for more information regarding investment opportunities and collaborations.
Email: partners@immunother.com